论文部分内容阅读
瑞士山道士药厂出版的《Sandorama》1981年第Ⅱ期报道:最近研究恶性高血压病因方面的主要因素是吸烟和遗传素质,也提示了免疫因素可能起的作用。作者等考虑到这个因素,对20名原发性高血压病人测定了他们的免疫状况,这些病人都是经过世界卫生组织规定标准的恶性期而存活者。在用药后全部病例的恶性期逆转,并用眼底镜检发现有Ⅰ或Ⅱ级改变。以年龄及性别相当的正常血压健康者作为对照。
Sandorama, published by the Swiss Hills Pharmaceuticals, reported in Phase II, 1981: Recent research into the etiology of malignant hypertension is based on smoking and genetic predispositions and suggests the possible role of immune agents. Taking into account this factor, the authors determined the immune status of 20 essential hypertensive patients who survived the malignancy that was standardized by the World Health Organization. After treatment in all cases of malignant phase reversal, and found with fundus I or II level change. The control subjects were normotensive and normotensive adults of the same age and gender.